Your browser doesn't support javascript.
loading
COVID-19 vaccine hesitancy in underserved communities of North Carolina.
Doherty, Irene A; Pilkington, William; Brown, Laurin; Billings, Victoria; Hoffler, Undi; Paulin, Lisa; Kimbro, K Sean; Baker, Brittany; Zhang, Tianduo; Locklear, Tracie; Robinson, Seronda; Kumar, Deepak.
Afiliação
  • Doherty IA; Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, United States of America.
  • Pilkington W; Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, United States of America.
  • Brown L; Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, United States of America.
  • Billings V; Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, United States of America.
  • Hoffler U; Division of Research and Sponsored Programs, North Carolina Central University, Durham, NC, United States of America.
  • Paulin L; Department of Mass Communication, North Carolina Central University, Durham, NC, United States of America.
  • Kimbro KS; Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, United States of America.
  • Baker B; Department of Nursing, North Carolina Central University, Durham, NC, United States of America.
  • Zhang T; Department of Mass Communication, North Carolina Central University, Durham, NC, United States of America.
  • Locklear T; Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, United States of America.
  • Robinson S; Department of Public Health Education, North Carolina Central University, Durham, NC, United States of America.
  • Kumar D; Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, United States of America.
PLoS One ; 16(11): e0248542, 2021.
Article em En | MEDLINE | ID: mdl-34723973
ABSTRACT

BACKGROUND:

In the United States, underserved communities including Blacks and Latinx are disproportionately affected by COVID-19. This study sought to estimate the prevalence of COVID-19 vaccine hesitancy, describe attitudes related to vaccination, and identify correlates among historically marginalized populations across 9 counties in North Carolina.

METHODS:

We conducted a cross-sectional survey distributed at free COVID-19 testing events in underserved rural and urban communities from August 27 -December 15, 2020. Vaccine hesitancy was defined as the response of "no" or "don't know/not sure" to whether the participant would get the COVID-19 vaccine as soon as it became available.

RESULTS:

The sample comprised 948 participants including 27.7% Whites, 59.6% Blacks, 12.7% Latinx, and 63% female. 32% earned <$20K annually, 60% owned a computer and ~80% had internet access at home. The prevalence of vaccine hesitancy was 68.9% including 62.7%, 74%, and 59.5% among Whites, Blacks, and Latinx, respectively. Between September and December, the largest decline in vaccine hesitancy occurred among Whites (27.5 percentage points), followed by Latinx (17.6) and only 12.0 points among Blacks. 51.2% of respondents reported vaccine safety concerns, 23.7% wanted others to get vaccinated first, and 63.1% would trust health care providers about the COVID-19 vaccine. Factors associated with hesitancy in multivariable logistic regression included being female (OR = 1.90 95%CI [1.36, 2.64]), being Black (OR = 1.68 1.16, 2.45]), calendar month (OR = 0.76 [0.63, 0.92]), safety concerns (OR = 4.28 [3.06, 5.97]), and government distrust (OR = 3.57 [2.26, 5.63]).

CONCLUSIONS:

This study engaged the community to directly reach underserved minority populations at highest risk of COVID-19 that permitted assessment of vaccine hesitancy (which was much higher than national estimates), driven in part by distrust, and safety concerns.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: PLoS One Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: PLoS One Ano de publicação: 2021 Tipo de documento: Article